<DOC>
<DOCNO>
EP-0002589
</DOCNO>
<TEXT>
<DATE>
19790627
</DATE>
<IPC-CLASSIFICATIONS>
A61K-35/66 A61K-31/35 C07H-15/04 A61P-31/00 C07H-15/18 C12P-19/00 C12P-19/44 C12P-19/56 <main>C12P-7/00</main> C07G-11/00 C07H-15/00 C12P-7/62 C07C-69/14 C12P-1/02 A61K-31/21 A61P-31/04 A61K-31/22 
</IPC-CLASSIFICATIONS>
<TITLE>
a-40104 antibiotics, their preparation, and formulations containing them.
</TITLE>
<APPLICANT>
lilly co elius<sep>eli lilly and company<sep>eli lilly and company307, east mccarty streetindianapolis indiana 46285us<sep>eli lilly and company<sep>
</APPLICANT>
<INVENTOR>
higgens calvin eugene<sep>michel karl heinz<sep>higgens, calvin eugene<sep>michel, karl heinz<sep>higgens, calvin eugene215, benningtonindianapolis indianaus<sep>michel, karl heinz255 e. north street, apt. 2205indianapolis indianaus<sep>higgens, calvin eugene<sep>michel, karl heinz<sep>higgens, calvin eugene215, benningtonindianapolis indianaus<sep>michel, karl heinz255 e. north street, apt. 2205indianapolis indianaus<sep>
</INVENTOR>
<ABSTRACT>
the novel a-40104 antibiotic complex, comprising active  factors a, b, c, and d, is produced by the novel submerged  aerobic fermentation of the new strain of clitopilus pseudopinsitus  nrrl 11179.  individual factors a, b, and c have  been isolated.  a-40104 factor c is the known antibiotic  pleuromutilin.  a-40104 factors a and b are novel antibiotics  related to pleuromutilin, a-40104 factor a, the major new  factor, is the d-xylose acetal derivative of pleuromutilin.   a-40104 factors a and b, their 19, 20-dihydro derivatives and  the per(c₂-c₆)-alkanoyl derivatives of factors a and b and of  their 19, 20-dihydro derivatives are active against gram-positive  and gram-negative bacteria, anaerobic bacteria, and  mycoplasma.  
</ABSTRACT>
</TEXT>
</DOC>
